Westlake BioPartners Fund II L.P. 13D and 13G filings for Acelyrin, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-05-19 2:54 pm Purchase |
2023-05-09 | 13D | Acelyrin, Inc. SLRN |
Westlake BioPartners Fund II L.P. | 9,852,020 10.100% |
9,852,020 (New Position) |
Filing |